FLUEQUIN H, emulsion for injection for horses
Homepage News News in assortment FLUEQUIN H, emulsion for injection for horses
9.3.2015
![FLUEQUIN H, emulsion for injection for horses FLUEQUIN H, emulsion for injection for horses](/obrazek.php?id=464-10-3-2015-nahled.jpeg)
New vaccine for the active immunization of horses to reduce the incidence of respiratory infections and clinical symptoms caused by influenza virus and equine herpesvirus horses (EHV-1)
- Contains current strain EHV-1 isolated in the Czech Republic, which also provides cross immunity against EHV-4
- Includes new strains of influenza viruses in accordance with the recommendations of the OIE
- Excellent tolerability and low application rate 1 ml intramuscular injection
- Packing: 2x1 dose, 10x1 dose
One dose (1 ml) of the vaccine contains:
Active substances:
Inactivated virus equine influenza, strain:
A/Equi 2 Morava 95 - Min. 6.0 log2 HIT1
A/Equi 2 Brno 08 - Min. 6.0 log2 HIT1
Inactivated equine herpes virus (EHV-1) - Min. 2.1 log10 VNI2
1 geometrical average of specific antibodies determinated by heamagglutination inhibition test in serum of guinea pigs
2 Virus neutralization index determined in serum of hamsters
Adjuvant(s): Oil adjuvans (Montanide ISA 35 VG) - 0.25 ml
Excipient(s): Thiomersal - 0.1 mg
INDICATION(S)
For the active immunization of horses to reduce the incidence of respiratory infections and clinical symptoms caused by influenza virus and equine herpesvirus horses (EHV-1).
Onset of Immunity: 14 days after primary vaccination
Duration of Immunity: 6 months after revaccination
For the active immunization of pregnant mares to reduce the incidence of abortion induced herpes virus infection of horses (EHV-1).
TARGET SPECIES
Horses
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
The vaccination dose – 1 ml
The vaccine (1 ml) is applied deep intramuscularly into the neck muscle; it is applied into the pectoral muscle only exceptionally in case of restless horses.
Primary vacciantionagainst influenza and equine herpes virus:
1st vaccination at the age of 6 months; 2nd vaccination after 4 weeks;
Revaccinationagainst influenza and equine herpes virus:
The first revaccination (third dose) should be administered 3 months after primary vaccination and each following revaccination is applied every six months.
Vaccination pregnant mares:
To reduce the incidence of abortion caused by equine herpesvirus infection is administered 1 dose of the vaccine in pregnant mares in the second month after admission and at 5 to 6th and the 9th month of pregnancy.
ADVICE ON CORRECT ADMINISTRATION
Before use, the contents of the vial warm up a temperature of 15-25 ° C and the content of the vial shaken well
WITHDRAWAL PERIOD
Zero days
SPECIAL STORAGE PRECAUTIONS
Keep out of the reach and sight of children. Store in a refrigerator (2 °C – 8 °C)
Protect from light. Store in a dry place. Shelf-life after first opening the container: 10 hours
PACKAGE
2 x 1 doses, 10 x 1 doses